Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

235studies shown

Showing 193-204 of 235

Drug study icon

RecruitingNCT07059377

Semaglutide for Smoking Cessation in people with Diabetes

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AddictionDrugOver 18 Years

Countries: Canada
Sponsor: Ottawa Heart Institute Research Corporation
Condition: Addiction

Behavioral study icon

RecruitingNCT06035809

Sensory Motor Arousal Regulation Treatment (SMART) Study

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

PTSDBehavioralFrom 18 Years to 65 Years

Countries: Canada
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition: PTSD

Drug study icon

RecruitingNCT06081348

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

ADHD, AnxietyDrugFrom 8 Years to 17 Years

Countries: Canada
Sponsor: Holland Bloorview Kids Rehabilitation Hospital
Condition: ADHD, Anxiety

Behavioral study icon

RecruitingNCT01980147

Skills for Wellness

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Schizophrenia, Bipolarity, ...BehavioralFrom 9 Years to 21 Years

Countries: Canada
Sponsor: Nova Scotia Health Authority
Condition: Schizophrenia, Bipolarity, ...

Behavioral study icon

RecruitingNCT05515354

Smoking Cessation and Menstrual Cycle Phase

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AddictionBehavioralFrom 18 Years to 40 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Addiction

Drug study icon

RecruitingNCT05585229

Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AddictionDrugFrom 19 Years to 75 Years

Countries: Canada
Sponsor: University of British Columbia
Condition: Addiction

Other study type icon

RecruitingNCT03100656

Food Aversion in people with Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Eating disordersOtherFrom 18 Years to 55 Years

Countries: United States, Canada
Sponsor: University of California, San Diego
Condition: Eating disorders

Behavioral study icon

RecruitingNCT05500001

Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaBehavioralFrom 17 Years to 27 Years

Countries: Canada
Sponsor: University of Alberta
Condition: Schizophrenia

Drug study icon

RecruitingNCT02639702

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDrugOver 18 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Schizophrenia

Drug study icon

RecruitingNCT07439549

Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility study

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AddictionDrugOver 19 Years

Countries: Canada
Sponsor: Pouya Azar
Condition: Addiction

Behavioral study icon

RecruitingNCT06560957

SYNCED - SYNChronized Eating in Depression in bipolarity Study

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Bipolarity, DepressionBehavioralFrom 18 Years to 55 Years

Countries: Canada
Sponsor: University of Ottawa
Condition: Bipolarity, Depression

Drug study icon

RecruitingNCT06798324

tDCS Plus Varenicline for Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AddictionDrugFrom 18 Years to 85 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.